Table 3.
Average difference in D99 of the Prostate‐CTV between the daily and planned dose.
CTV Expansion (39) | ||||||||
---|---|---|---|---|---|---|---|---|
Registration Methods | 0 | 2 | 4 | 6/4 | ||||
ROT_NC |
|
|
|
|
||||
ROT_C |
|
|
|
|
||||
ContourT |
|
|
|
|
||||
Improvement by correction | 4.4% | 6.9% | 8.3% | 7.1% |
Note: The differences are expressed in percentage (%) of the planned D99 of the prostate as a function of CTV expansion margins. Negative mean value indicates less dose in daily D99 of the Prostate‐CTV when compared to the planned dose.